1 completed, 1 enrolling by invitation, 1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Hernando Gomez: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CRUISE System in Flight Observation blinded group with the purpose of assessing the safety of a non-invasive decision support system for the identification and management of shock (the CRUISE system). - Shock | Not yet recruiting | Hernando Gomez | 60 | 2026-09-01 | 2026-08-10 | |
| CTICU Device Study CRUISE CRUISE CTICU CareTaker Vitalstream Device, CRUISE CTICU CNAP Device, CRUISE CTICU Edwards Clearsight Device - Open Heart Surgery | Enrolling by invitation | Hernando Gomez | 50 | 2025-06-03 | 2026-03-06 | |
| Safety and Feasibility of Metformin for Sepsis Induced AKI Metformin low dose, Metformin high dose, Placebo - Sepsis, Septic Shock | Phase 2 | Completed | Hernando Gomez | 80 | 2023-11-08 | 2026-06-09 |
Acute Kidney Injury (1) · Emergencies (1) · Sepsis (1) · Shock (1) · Shock, Septic (1) · Wounds and Injuries (1)
Metformin (1)
United States (2)
R01DK133142 (1)